JAG1 and colorectal carcinoma: The resistance to OXP/5FU drugs protects Jagged1-overexpressing CRC cells from apoptosis through the activation of Jag1-ICD-dependent pro-survival targets, also under genotoxic stress induced by chemotherapeutic agents.